CARCINOMAS
Clinical trials for CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new CARCINOMAS trials appear
Sign up with your email to follow new studies for CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to stop lung cancer recurrence in High-Risk patients
⭐️ VACCINE ⭐️ TerminatedThis study tests a vaccine made from lung cancer cells, combined with an immune-boosting drug (N-803), to see if it can stop non-small cell lung cancer from returning after surgery. About 30 adults with no signs of cancer after surgery will receive the vaccine and N-803 injection…
Matched conditions: CARCINOMAS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 16:31 UTC
-
New hope for rare cervical cancer: drug trial targets tumor control
Disease control OngoingThis study tests a drug called AK104 (Cadonilimab) in 18 adults with a rare, fast-growing cervical cancer that has come back or spread. The goal is to see if the drug can stop the cancer from growing for at least 6 months. Participants must have already tried standard chemotherap…
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 07, 2026 16:33 UTC